VBI Vaccines
VBIV
#10526
Rank
NZ$3.15 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.74%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): NZ-$16.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is NZ-$17.05. In 2022 the company made an earnings per share (EPS) of NZ-$22.20 a decrease over its 2021 EPS that were of NZ-$13.62.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$16.49
2022NZ-$22.2062.96%
2021NZ-$13.6228.57%
2020NZ-$10.60-54.35%
2019NZ-$23.21-52.58%
2018NZ-$48.9410.23%
2017NZ-$44.4014.29%
2016NZ-$38.85-62.8%
2015NZ-$104.4590.68%
2014NZ-$54.78-7.95%
2013NZ-$59.51-57.97%
2012NZ-$141.60-78%
2011NZ-$643.753151.47%
2010NZ-$19.8023.87%
2009NZ-$15.98-18.48%
2008NZ-$19.6112.08%
2007NZ-$17.50-49.47%
2006NZ-$34.62
2005N/A-100%
2004NZ-$15.3911.94%
2003NZ-$13.75-81.89%
2002NZ-$75.93196.44%
2001NZ-$25.6184.33%
2000NZ-$13.89-65.37%
1999NZ-$40.13-29.45%
1998NZ-$56.8729.61%
1997NZ-$43.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.60-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ-$6.17-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.28-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA